Literature DB >> 11709854

Lactic acid bacteria and their effect on the immune system.

G Perdigón1, R Fuller, R Raya.   

Abstract

Lactic acid bacteria (LAB) are present in the intestine of most animals. The beneficial role played by these microorganisms in the humans and other animals, including the effect on the immune system, has been extensively reported. They are present in many foods and are frequently used as probiotics to improve some biological functions in the host. The activation of the systemic and secretory immune response by LAB requires many complex interactions among the different constituents of the intestinal ecosystem (microflora, epithelial cells and immune cells). Through different mechanisms they send signals to activate immune cells. Thus the knowledge of the normal intestinal microflora, the contribution of LAB and their role in the numerous functions in the digestive tract as well as the functioning of the mucosal immune system form the basis for the study and selection of a probiotic strain with immunostimulatory properties. In the selection of LAB by their immunostimulatory capacity it helps to know not only the effect which they have on the mucosal immune system, but the specific use to which these oral vaccine vectors are being put. Although there are reports of the protection of animals and humans against diseases such as microbial infections and cancer, more work remains to be done on the factors affecting the design of oral vaccine vectors and the use of LAB for therapeutic purposes. The basic knowledge of LAB immunostimulation and the criteria for selection of LAB by their immunostimulatory capacity, will be extensively discussed and appraised in this review.

Entities:  

Mesh:

Year:  2001        PMID: 11709854

Source DB:  PubMed          Journal:  Curr Issues Intest Microbiol        ISSN: 1466-531X


  61 in total

1.  Population-Specific Responses to Interspecific Competition in the Gut Microbiota of Two Atlantic Salmon (Salmo salar) Populations.

Authors:  Xiaoping He; Subba Rao Chaganti; Daniel D Heath
Journal:  Microb Ecol       Date:  2017-07-16       Impact factor: 4.552

Review 2.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

3.  Effects of Lactobacillus gasseri BNR17 on body weight and adipose tissue mass in diet-induced overweight rats.

Authors:  Ji-Hee Kang; Sung-Il Yun; Han-Oh Park
Journal:  J Microbiol       Date:  2010-11-03       Impact factor: 3.422

4.  Immunogenicity in Swine of Orally Administered Recombinant Lactobacillus plantarum Expressing Classical Swine Fever Virus E2 Protein in Conjunction with Thymosin α-1 as an Adjuvant.

Authors:  Yi-Gang Xu; Xue-Ting Guan; Zhong-Mei Liu; Chang-Yong Tian; Li-Chun Cui
Journal:  Appl Environ Microbiol       Date:  2015-03-27       Impact factor: 4.792

5.  Immunogenicity of recombinant classic swine fever virus CD8(+) T lymphocyte epitope and porcine parvovirus VP2 antigen coexpressed by Lactobacillus casei in swine via oral vaccination.

Authors:  Yigang Xu; Lichun Cui; Changyong Tian; Guocai Zhang; Guicheng Huo; Lijie Tang; Yijing Li
Journal:  Clin Vaccine Immunol       Date:  2011-09-21

6.  Role of intestinal epithelial cells in immune effects mediated by gram-positive probiotic bacteria: involvement of toll-like receptors.

Authors:  Gabriel Vinderola; Chantal Matar; Gabriela Perdigon
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

7.  Dominance of Lactobacillus acidophilus in the facultative jejunal Lactobacillus microbiota of fistulated beagles.

Authors:  Yurui Tang; Titta J K Manninen; Per E J Saris
Journal:  Appl Environ Microbiol       Date:  2012-07-27       Impact factor: 4.792

8.  Induction of immune responses in mice after intragastric administration of Lactobacillus casei producing porcine parvovirus VP2 protein.

Authors:  Yigang Xu; Yijing Li
Journal:  Appl Environ Microbiol       Date:  2007-09-07       Impact factor: 4.792

9.  Randomised clinical trial of synbiotic therapy in elective surgical patients.

Authors:  A D G Anderson; C E McNaught; P K Jain; J MacFie
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

10.  In Silico and Experimental Data Claiming Safety Aspects and Beneficial Attributes of the Bacteriocinogenic Strain Enterococcus faecalis B3A-B3B.

Authors:  Alaa Al Seraih; Yanath Belguesmia; Benoit Cudennec; John Baah; Djamel Drider
Journal:  Probiotics Antimicrob Proteins       Date:  2018-09       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.